• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN Back to Search Results
Catalog Number 03P36-25
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.
 
Event Description
The customer observed (b)(6) alpha 1 fetoprotein (afp) results on the architect i2000sr analyzer.The following data was provided for a (b)(6) year old female patient: initial (b)(6), repeat (b)(6), (b)(6) ng/ml.The results were compared to another method (b)(6) ng/ml, which matches the clinical presentation of the patient.There was no impact to patient management reported.
 
Manufacturer Narrative
The likely cause size code was updated on march 22, 2019 from 03p36-26 to 03p36-25.An investigation is still in process.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of field data, and a review of labeling, as the product was used off-label.No adverse trend was identified for the customer's issue.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within expected limits.The labeling review found to adequately indicate this product is clearly labeled an aid in monitoring disease progression during the course of disease and treatment of patients with nonseminomatous testicular cancer and also to aid in the detection of fetal open neural tube defects.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Type of Device
ALPHA-FETOPROTEIN
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8426345
MDR Text Key142624112
Report Number3008344661-2019-00029
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
PMA/PMN Number
P120008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/17/2019
Device Catalogue Number03P36-25
Device Lot Number88061FN00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/10/2019
Initial Date FDA Received03/16/2019
Supplement Dates Manufacturer Received03/22/2019
07/29/2019
Supplement Dates FDA Received03/22/2019
07/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LN 03M74-01 SN (B)(4) ; LN 03M74-01 SN (B)(4) ; LN 03M74-01 SN(B)(4)
Patient Age63 YR
-
-